Biotika a.s. (BSSE:1BSL01AE)

Slovakia · Delayed Price · Currency is EUR

17.00

0.00 (0.00%)

At close: Oct 14, 2026

Market Cap	11.90M +120.8%
Revenue (ttm)	18.15M +5.3%
Net Income	-1.19M
EPS	-1.70
Shares Out	700.00K
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (2.94%)
Ex-Dividend Date	n/a

Volume	3
Open	17.00
Previous Close	n/a
Day's Range	17.00 - 17.00
52-Week Range	9.00 - 23.00
Beta	0.03
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 23, 2026

About Biotika a.s.

Biotika a.s., a biotechnology company, manufactures active pharmaceutical ingredients in Slovakia and internationally. It is involved in manufacturing Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate; contract manufacturing of Gramicidin S Hydrocholoride; import and distribution of active ingredients; production of chemical products, such as disinfectants and organic chemicals; and production of human and veterinary medicines, food products, including beverages, protein substances, and derivatives. The company also engages in research ... [Read more]

Industry Pharmaceutical Preparations

Founded 1953

Employees 165

Stock Exchange Bratislava Stock Exchange

Ticker Symbol 1BSL01AE

Full Company Profile

Financial Performance

In 2025, Biotika a.s.'s revenue was 18.15 million, an increase of 5.30% compared to the previous year's 17.24 million. Losses were -1.19 million, -50.25% less than in 2024.

Financial Statements